dry eye

Diagnosing and treating Sjögren's syndrome
Diagnosing and treating Sjögren's syndromeSjögren’s syndrome is underdiagnosed and seriously impacts the ocular surface and quality of life and places the patient at risk for multisystem involvement. Optometry’s role in identification, diagnosis and collaborative long-term management is an important one. Earlier attention to symptoms leading to diagnosis and collaboration with other health professionals will ensure better quality of life for our patients.
IL-1 receptor inhibitor fails on ocular itching endpointIsunakinra, an interleukin-1 signaling inhibitor designed for topical ophthalmic administration, did not meet the primary endpoint in a phase III clinical trial for the treatment of moderate-to-severe allergic conjunctivitis.
3 ways ODs can combat 1-800-EYE-EXAM
3 ways ODs can combat 1-800-EYE-EXAMThe recent announcement that 1-800 Contacts has partnered with online eye exam provider Opternative to offer consumers eye exams online has rocked the optometry community. What can we learn from this announcement, and what should we do?
Understanding and defining MGDThe Tear Film and Ocular Surface Society’s Meibomian Gland Workshop was tasked to sort through the literature to determine proper terminology of conditions affecting the lid margin. Review the terminology, gland anatomy, gland expression classifications, and treatment strategies.
Portable device offers rapid high-definition meibomian gland imaging
Portable device offers rapid high-definition meibomian gland imagingA new compact, portable device for rapid, high-definition meibomian gland imaging (LipiScan, TearScience) is an efficient screening tool for patients with complaints of dry eye and/or candidates for surgical procedures in which pre-existing dry eye could affect outcomes.
Using dry eye treatments for sick corneasDid you ever consider that those tools in your dry eye arsenal are also good for acutely sick eyes? I recently had a patient who drove this point home…even to my ophthalmology partner.
Shire gets FDA nod for Xiidra (lifitegrast) for dry eye
Shire gets FDA nod for Xiidra (lifitegrast) for dry eyeShire plc obtained U.S. Food and Drug Administration (FDA) approval for Xiidra (lifitegrast ophthalmic solution) 5%, a twice-daily eye drop indicated for the treatment of the signs and symptoms of dry eye disease in adult patients.
Shire's FDA-approved drug ends dry eye treatment drought
Shire's FDA-approved drug ends dry eye treatment droughtOphthalmologists have been waiting more than a decade for a new treatment option for their dry eye patients—and the anticipation is finally over. Lifitegrast ophthalmic solution 5% (Xiidra, Shire Ophthalmics) is a twice-daily eye drop solution and is the only FDA-approved drug indicated to treat the signs and symptoms of dry eye disease, according to the company.
Revive tired dry eyes; safely clear ears of wax buildupNew OTC products for eyes and ears.
4 steps to beating blepharitisBlepharitis is an inflammatory condition of the eyelids leading to red, irritated, itchy, and dandruff-like scales that form on the eyelashes.